Preclinical Evaluation of Hypertonic Saline as Therpay for Cystic Fibrosis Lung Disease in Mice

Ähnliche Einträge

• Preventive inhalation of hypertonic saline in infants with cystic fibrosis (PRESIS): a randomized, double-blind, controlled study
  von: Stahl, Mirjam, et al.
  Veröffentlicht: (2019)
• Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease
  von: Gräber, Simon Y., et al.
  Veröffentlicht: (2013)
• Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice
  von: Mall, Marcus A., et al.
  Veröffentlicht: (2014)
• Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases
  von: Stahl, Mirjam, et al.
  Veröffentlicht: (2018)
• Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease
  von: Gehrig, Stefanie, et al.
  Veröffentlicht: (2014)